HI
SGMO

Hudock Inc’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Hudock Inc’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,200
Closed -$10K – 624
2022
Q3 		$10K Buy
+2,200
New +$11.3K ﹤0.01% 531
2015
Q1 		– Sell
-1,000
Closed -$15K – 614
2014
Q4 		$15K Hold
1,000
– – 0.01% 350
2014
Q3 		$11K Hold
1,000
– – 0.01% 385
2014
Q2 		$15K Hold
1,000
– – 0.02% 361
2014
Q1 		$18K Hold
1,000
– – 0.02% 325
2013
Q4 		$14K Hold
1,000
– – 0.01% 352
2013
Q3 		$10K Hold
1,000
– – 0.01% 333
2013
Q2 		$8K Buy
+1,000
New +$8.72K 0.01% 361

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hudock Inc's SGMO Position: Q4 2022 in Review

Hudock Inc sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 2,200 shares — an estimated $10K sold.

Hudock Inc first reported a position in SGMO in Q2 2013 and held it in 8 quarters. The position peaked at $18K in Q1 2014. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Hudock Inc reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 2,200 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $10K.
  • Hudock Inc first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 8 quarters.
  • Hudock Inc's SANGAMO THERAPEUTICS INC position peaked at $18K in Q1 2014.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.